A promising cancer therapy, in which the SCK CEN nuclear research center in Mol is participating, depends on ElektroKhimPribor (EKP), the most important Russian nuclear weapons company and a subsidiary of the Russian state-owned company Rosatom. This was evident from a survey on Saturday by De Tijd, the Swedish newspaper Expressen and the Dutch NOS/Nieuwsuur.
ttn-3
Promising cancer therapy depends on Russian nuclear weapons company
